Blood Pressure During Rate Control in Patients With Tachycardic Atrial Fibrillation at the Emergency Department
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Atrial Fibrillation
- Sponsor
- Medical University of Vienna
- Enrollment
- 140
- Primary Endpoint
- Mean and maximum blood pressure difference between before (baseline) and during/after medication.
- Last Updated
- 6 years ago
Overview
Brief Summary
The aim of this study is to analyse blood pressure during rate control therapy in patients with tachycardic atrial fibrillation in a real-world emergency cohort.
Detailed Description
Atrial fibrillation (AF) is the primary clinical problem in 3.3% to 10.0 % emergency department (ED) admissions. Rate control is an integral part of the management of symptomatic tachycardic AF patients. According to the recent guidelines beta-blockers, digoxin, the calcium channel blockers diltiazem and verapamil, amiodarone or combination therapy should be considered for rate control. Haemodynamic side-effects in particular hypotension may occur. Heart rate and blood pressure behavior in an ED population during rate control therapy in patients with tachycardic atrial fibrillation will be analysed.
Investigators
Hans Domanovits
Principal Investigator
Medical University of Vienna
Eligibility Criteria
Inclusion Criteria
- •Age \> 18 years
- •Atrial fibrillation or atrial flutter and heart rate ≥ 110 bpm
- •Indication for rate control
- •Informed consent
Exclusion Criteria
- •Inclusion criteria not met
Outcomes
Primary Outcomes
Mean and maximum blood pressure difference between before (baseline) and during/after medication.
Time Frame: 20th July 2019 to 20th July 2021